One of Dr. Dattwyler's research group's aims is the development of new diagnostic tests for infectious diseases, including Lyme disease. The goal is to provide assays that are more sensitive and specific then current assays, especial in early Lyme disease. Timely diagnosis enables prompt treatment leading to better patient outcomes.
The research, both clinical and translational, bridges the gap between basic science research and clinical medicine. With funding from the NIH, Dr. Dattwyler's group is working to develop new diagnostic tests for a number of infectious diseases. The new Lyme tests in development are designed to fill the gaps that exist in testing today, moving away from the cumbersome Western blot technology to a more accurate, more user friendly test technology.